| extracellular matrix organization | GO:0030198 | 147 | 0.274 | |
| extracellular structure organization | GO:0043062 | 148 | 0.259 | |
| peptidyl proline hydroxylation | GO:0019511 | 3 | 0.209 | |
| chondrocyte development | GO:0002063 | 24 | 0.133 | |
| protein hydroxylation | GO:0018126 | 4 | 0.132 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.123 | |
| telencephalon development | GO:0021537 | 186 | 0.096 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.081 | |
| collagen fibril organization | GO:0030199 | 32 | 0.079 | |
| ossification | GO:0001503 | 216 | 0.068 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.066 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.064 | Yeast |
| positive regulation of cell death | GO:0010942 | 224 | 0.060 | |
| response to growth factor | GO:0070848 | 198 | 0.054 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.054 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.053 | |
| response to acid chemical | GO:0001101 | 111 | 0.049 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.048 | |
| ear development | GO:0043583 | 200 | 0.046 | |
| protein folding | GO:0006457 | 28 | 0.043 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.042 | |
| negative regulation of nik nf kappab signaling | GO:1901223 | 2 | 0.041 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.040 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.039 | |
| anion transport | GO:0006820 | 177 | 0.034 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.033 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.033 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.032 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.032 | |
| dna metabolic process | GO:0006259 | 303 | 0.030 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.030 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.030 | |
| skeletal system development | GO:0001501 | 356 | 0.030 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.029 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.029 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.029 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.029 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.029 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.028 | |
| protein processing | GO:0016485 | 163 | 0.028 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.027 | |
| forebrain development | GO:0030900 | 302 | 0.027 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.027 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| regulation of cell migration | GO:0030334 | 219 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| cellular response to lipid | GO:0071396 | 145 | 0.025 | |
| peptidyl proline modification | GO:0018208 | 6 | 0.025 | Yeast |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.025 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.025 | |
| protein maturation | GO:0051604 | 176 | 0.025 | |
| cerebral cortex development | GO:0021987 | 86 | 0.025 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.024 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.024 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.024 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.024 | |
| muscle fiber development | GO:0048747 | 76 | 0.023 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.023 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.023 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.023 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.023 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.022 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| protein secretion | GO:0009306 | 111 | 0.022 | |
| regulation of protein transport | GO:0051223 | 163 | 0.022 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.022 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.022 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.022 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.021 | |
| bone development | GO:0060348 | 120 | 0.021 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.021 | |
| palate development | GO:0060021 | 76 | 0.021 | |
| connective tissue development | GO:0061448 | 179 | 0.021 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.021 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.020 | |
| tissue homeostasis | GO:0001894 | 115 | 0.020 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.020 | |
| organic acid transport | GO:0015849 | 101 | 0.020 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.020 | |
| endoderm development | GO:0007492 | 45 | 0.020 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.020 | |
| organic anion transport | GO:0015711 | 137 | 0.020 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.019 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.019 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.019 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.019 | |
| endomembrane system organization | GO:0010256 | 147 | 0.018 | |
| activation of immune response | GO:0002253 | 138 | 0.018 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.018 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.018 | |
| cell growth | GO:0016049 | 130 | 0.018 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.018 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.018 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.018 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.018 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.017 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| muscle tissue development | GO:0060537 | 308 | 0.017 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| blood coagulation | GO:0007596 | 76 | 0.017 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.017 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.017 | |
| immune effector process | GO:0002252 | 321 | 0.017 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.017 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.016 | |
| regulation of secretion | GO:0051046 | 274 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.016 | |
| protein catabolic process | GO:0030163 | 221 | 0.016 | |
| appendage development | GO:0048736 | 166 | 0.016 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.016 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.016 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.016 | |
| endoderm formation | GO:0001706 | 20 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| organelle localization | GO:0051640 | 179 | 0.015 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.015 | |
| bone morphogenesis | GO:0060349 | 78 | 0.015 | |
| response to radiation | GO:0009314 | 165 | 0.015 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.015 | |
| regulation of integrin mediated signaling pathway | GO:2001044 | 8 | 0.015 | |
| cell adhesion | GO:0007155 | 329 | 0.015 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.015 | |
| blood circulation | GO:0008015 | 195 | 0.015 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.015 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.015 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.015 | |
| ear morphogenesis | GO:0042471 | 118 | 0.014 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.014 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.014 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.014 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.014 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.014 | |
| sensory perception of sound | GO:0007605 | 97 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.014 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.014 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.014 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.014 | |
| notochord development | GO:0030903 | 20 | 0.014 | |
| hair follicle development | GO:0001942 | 85 | 0.014 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.014 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.014 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.014 | |
| male gamete generation | GO:0048232 | 285 | 0.014 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.014 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.014 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.013 | |
| spermatogenesis | GO:0007283 | 284 | 0.013 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.013 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.013 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.013 | |
| lipid transport | GO:0006869 | 98 | 0.013 | |
| defense response to virus | GO:0051607 | 68 | 0.013 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.013 | |
| regulation of coagulation | GO:0050818 | 31 | 0.013 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.013 | |
| phagocytosis | GO:0006909 | 66 | 0.013 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.013 | |
| peptide secretion | GO:0002790 | 114 | 0.013 | |
| defense response to other organism | GO:0098542 | 197 | 0.013 | |
| compound eye development | GO:0048749 | 1 | 0.013 | |
| wound healing | GO:0042060 | 157 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.013 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.012 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.012 | |
| fibrinolysis | GO:0042730 | 3 | 0.012 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.012 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.012 | |
| regulation of cell activation | GO:0050865 | 289 | 0.012 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.012 | |
| intracellular protein transport | GO:0006886 | 204 | 0.012 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.012 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.012 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.012 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.012 | |
| respiratory tube development | GO:0030323 | 167 | 0.012 | |
| positive regulation of neutrophil apoptotic process | GO:0033031 | 1 | 0.012 | |
| pallium development | GO:0021543 | 120 | 0.012 | |
| cellular homeostasis | GO:0019725 | 240 | 0.011 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.011 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.011 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.011 | |
| regulation of protein binding | GO:0043393 | 60 | 0.011 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.011 | |
| transmembrane transport | GO:0055085 | 412 | 0.011 | |
| lateral line system development | GO:0048925 | 1 | 0.011 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.011 | |
| regulation of cell motility | GO:2000145 | 236 | 0.011 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.011 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.011 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.011 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.011 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.011 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.011 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.011 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.011 | |
| dna conformation change | GO:0071103 | 37 | 0.011 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.011 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.011 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.011 | |
| neuromuscular process | GO:0050905 | 99 | 0.011 | |
| head morphogenesis | GO:0060323 | 34 | 0.011 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.011 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.011 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.011 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.010 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.010 | |
| neuron migration | GO:0001764 | 122 | 0.010 | |
| gliogenesis | GO:0042063 | 141 | 0.010 | |
| skin development | GO:0043588 | 220 | 0.010 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.010 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.010 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.010 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.010 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.010 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.010 | |
| dna topological change | GO:0006265 | 2 | 0.010 | |
| cardiac chamber development | GO:0003205 | 108 | 0.010 | |
| endodermal cell differentiation | GO:0035987 | 14 | 0.010 | |